This startup is developing an animal collar that automatically administers topical medicine – GeekWire

From left: Co-Founder and Chief Technology Officer Steve Leith, CEO and Co-Founder Michael Mannion, and Strategic Advisor David Kraft. (JetMeds images)

In order to treat your pet properly, a lot has to go right. Not only do you need to remember to buy the remedy, but you also need to make sure that you apply it consistently.

A Seattle-based startup wants to automate pet medicine management.

Jet MedsA smart collar automatically applies precise doses of topical treatments directly to an animal’s fur using a mobile app that tracks treatment schedule and provides updates. The company plans to launch the product in 2024.

The startup, founded last year, aims to address the pain point of animal medicine, where every product on the market comes with its own set of challenges, special advisor David Craft Tell GeekWire in an email. He points out that topical treatments are messy and lead to exposure to the family and the environment; Chews require the pet owner to remember to do the treat; And some polymer collars have Safety concerns.

He added that recent advances in inkjet printing and microfluidic technology made the development of the smart collar device possible. JetMeds recently completed a 5-month study that showed the collar to have full efficacy against fleas, using only 25% of the typical monthly dose. The collar works by adding a layer of fluid that spreads over the animal’s fur.

Kraft said the smart collar will dispense a liquid designed for topical or transdermal treatments. The device will shoot small amounts of liquid onto the animal’s skin or fur at a “high speed”.

The startup is made up of 7 people Michael Mannion, who also runs a research and development company called Keon Research. Join him Steve Leith, former chief engineering officer at Carlisle Interconnect Technologies. And Kraft who ex Served as Chief Innovation Services Officer at the Xinova Innovation Lab in Seattle

JetMeds collar prototype. (JetMeds images)

JetMeds will partner with pet and animal pharmaceutical manufacturers to supply treatments that will be administered through the collar.

According to Kraft, there are a variety of topical medications that can be sold as cartridges. Short-term applications include parasiticides, worming, repellents, and anti-infectives. It also plans to integrate anti-inflammatories and analgesics, and possibly enter the hygiene and personal care market, with products such as perfumes and conditioners.

The business model will be similar to printer companies. Customers will purchase the collar first, then re-order the medication cartridges when they run out.

Kraft said the JetMeds will cost about the same as other smart collars on the market. fi And the whistle The GPS tracking collars sell for $149 and $79, respectively.

JetMeds will be pursuing an expanding pet care market, which has been fueled by the pet pandemic boom. As of April 2022, inflation-adjusted spending on pets and related products was 28% higher than it was in January 2019 The Wall Street Journal reportedCompared to 9.6% growth for groceries during the same period.

Last year, venture capitalists invested a record amount of capital in pet-related startups, Published more than 1 billion during the first eight months of the year. And this year though in its entirety Venture capital spending slowedInvestors are still backing pet healthcare startups. Last week, I started MySimplePetLab for pet diagnostics Collect $5 millionwhile Nabu pet insurance startup It raised £15 million.

JetMeds recently raised $1 million in direct funding through a combination of self-funding and corporate partnerships. It plans to raise an additional $3.5-5 million in the first round over the next year.

One of the remaining challenges in developing the collar before taking it to market, Kraft said, was making sure it was durable and functional. During animal trials, a few dogs chewed on smart collars.

“It turns out that dogs get a little bored,” he said.

Leave a Comment